C-Reactive Protein and Carotid Intimal Medial Thickness in a Community Population

Background C-reactive protein (CRP) has been linked to cardiovascular disease and atherosclerosis. Large-scale epidemiological studies have shown a correlation of CRP level with risk of stroke, myocardial infarction and peripheral arterial disease. Nevertheless, the question whether serum CRP itself is an independent indicator of the atherosclerotic process remains unanswered. Methods In a community-based sample free of advanced atherosclerotic disease (n=1018; mean age ± SD, 54.1 ± 12.0 years; 49.7% women) we examined the relationship between carotid intimal medial thickness (IMT), conventional vascular risk factors (that is, smoking, obesity, elevated blood pressure, diabetes mellitus, hypercholesterolaemia) and serum CRP. Results We found an association between increasing IMT values with increasing CRP values for all sites within the carotid system (for example, common carotid artery [CCA-] IMT, β=0.174, P < 0.001). The relationship was weakened after accounting for the above-mentioned conventional risk factors (linear regression), particularly body mass index, but remained significant (for example, mean CCA-IMT β=0.02, P=0.042). Including fibrinogen in the regression made the relationship no longer significant (mean CCA-IMT β=0.01, P=0.277). Conclusion It is unlikely that CRP per se is a major independent cause of early arteriosclerosis. Elevations of CRP, or less specifically chronic inflammation, may mediate the effect of certain conventional risk factors on promoting atherogenesis, especially obesity.

[1]  J. Pankow,et al.  Association of C-reactive protein with markers of prevalent atherosclerotic disease. , 2001, The American journal of cardiology.

[2]  ÜRGEN,et al.  HEMOSTATIC FACTORS AND THE RISK OF MYOCARDIAL INFARCTION OR SUDDEN DEATH IN PATIENTS WITH ANGINA PECTORIS , 2001 .

[3]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[4]  W. Cliff,et al.  Coronary C-reactive protein distribution: its relation to development of atherosclerosis. , 1999, Atherosclerosis.

[5]  A. Hofman,et al.  Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[6]  C. Visser,et al.  C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? , 1999, Circulation.

[7]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[8]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[9]  J. Turgeon,et al.  Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina. , 1998, American heart journal.

[10]  W. Koenig,et al.  C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[11]  P. Ridker,et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.

[12]  H. Steinmetz,et al.  Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. , 1998, Stroke.

[13]  H. Steinmetz,et al.  Modifiable Stroke Risk Factors in Volunteers Willing to Participate in a Prevention Program , 1998, Neuroepidemiology.

[14]  P L Allan,et al.  Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. , 1998, Circulation.

[15]  M. Mendall.  Inflammatory responses and coronary heart disease , 1998, BMJ.

[16]  P. Ridker,et al.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.

[17]  Ridker Pm,et al.  C-reactive protein and risks of future myocardial infarction and thrombotic stroke. , 1998 .

[18]  P. Ridker.  C-reactive protein and risks of future myocardial infarction and thrombotic stroke. , 1998, European heart journal.

[19]  R. Virmani,et al.  Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. , 1997, Surgery.

[20]  A. Maseri.  Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon. , 1997, The New England journal of medicine.

[21]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[22]  J. Salonen,et al.  Plasma fibrinogen and wall thickness in carotid and femoral arteries: findings from the KIHD study , 1997 .

[23]  T. Shimokama,et al.  Inflammatory and immunological nature of atherosclerosis. , 1996, International journal of cardiology.

[24]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[25]  J. Guyton,et al.  Development of the lipid-rich core in human atherosclerosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[26]  C. Yutani,et al.  Immunohistochemical localization of C‐reactive protein‐binding sites in human atherosclerotic aortic lesions by a modified streptavidin‐biotin‐staining method , 1995, Pathology international.

[27]  S. Thompson,et al.  Haemostasis Factors in Angina Pectoris; Relation to Gender, Age and Acute-phase Reaction , 1995, Thrombosis and Haemostasis.

[28]  T. L. Lane,et al.  Fully automated assay of glycohemoglobin with the Abbott IMx analyzer: novel approaches for separation and detection. , 1993, Clinical chemistry.

[29]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[30]  M. Mancini,et al.  Measuring plasma fibrinogen to predict stroke and myocardial infarction. , 1990, Arteriosclerosis.

[31]  G. Hansson,et al.  Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[32]  Reynolds Gd,et al.  C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. , 1987 .

[33]  R. Vance,et al.  C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. , 1987, Archives of pathology & laboratory medicine.

[34]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[35]  H. Rus,et al.  Immunoglobulins and complement components in human aortic atherosclerotic intima. , 1985, Atherosclerosis.

[36]  M. Pepys,et al.  C-reactive protein: binding to lipids and lipoproteins. , 1985, International review of experimental pathology.

[37]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .